SAFE PRO GROUP INC. financials

SPAI CIK 0002011208

Source: EDGAR filings · Built 2026-09-22T01:24:31Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2024FY 2024
Free Cash Flow -6.27M -4.16M -2.03M —
EBITDA -14.16M -6.81M -6.07M —
Working Capital 16.68M 1.86M -142.82K —
Net Debt -16.59M -1.73M -53.94K —
Gross Margin 33.33% 41.77% 33.90% —
Operating Margin -2397.56% -329.71% -687.24% —
Net Margin -2360.84% -342.46% -688.08% —
Return on Equity (ROE) -80.84% -191.73% -355.48% —
Return on Assets (ROA) -74.93% -150.07% -184.09% —
Current Ratio 14.33× 3.08× 0.90× —
Debt-to-Equity 0.01× 0.06× 0.37× —
Cash Conversion Ratio 0.43× 0.55× 0.32× —
Accruals Ratio -0.42× -0.67× -1.26× —
SBC % of Revenue 1.38% — — —
CapEx Coverage -127.36× -64.19× -66.42× —
Free Cash Flow Per Share $-0.37 $-0.39 $-0.25 —

Income Statement

Concept FY 2025FY 2024FY 2024FY 2024
Revenue from Contract with Customer, Excluding Assessed Tax 606.68K 2.17M 917.72K —
Cost of Revenue 404.50K 1.26M 606.64K —
Gross Profit 202.18K 906.15K 311.08K —
Research and Development Expense 394.21K 90.37K 373.65K —
Selling, General and Administrative Expense 2.13M 1.25M 449.87K —
Operating Expenses 14.75M 8.06M 6.62M —
Operating Income (Loss) -14.55M -7.15M -6.31M —
Net Income (Loss) Attributable to Parent -14.32M -7.43M -6.31M —
Earnings Per Share, Basic $-0.85 $-0.70 $-0.79 —
Weighted Average Number of Shares Outstanding, Basic 16.91M 10.61M 7.98M —
Earnings Per Share, Diluted $-0.85 $-0.70 $-0.79 —
Weighted Average Number of Shares Outstanding, Diluted 16.91M 10.61M 7.98M —

Balance Sheet

Concept FY 2025FY 2024FY 2024FY 2024
Assets, Current 17.93M 2.75M 1.27M —
Assets 19.11M 4.95M 3.43M —
Long-term Debt 146.00K 146.00K — —
Liabilities, Current 1.25M 893.93K 1.42M —
Liabilities 1.40M 1.08M 1.65M —
Stockholders' Equity Attributable to Parent 17.72M 3.87M 1.78M 2.58M
Common Stock, Shares, Outstanding 20.74M 14.53M 8.73M —

Cash Flow Statement

Concept FY 2025FY 2024FY 2024FY 2024
Net Cash Provided by (Used in) Operating Activities -6.22M -4.10M -2.00M —
Payments to Acquire Property, Plant, and Equipment 48.81K 63.80K 30.17K —
Net Cash Provided by (Used in) Investing Activities -241.35K -436.39K -30.17K —
Net Cash Provided by (Used in) Financing Activities 21.28M 5.80M 985.15K —

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (SPAI CIK 0002011208), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

GENB

Generate Biomedicines, Inc.

PLUR

Pluri Inc.

ALGS

Aligos Therapeutics, Inc.